Four tiny, implantable rods that steadily ooze drugs could help some patients kick opioid addictions, an advisory committee for the Food and Drug Administration concluded Tuesday. With a 12 to 5 vote, the committee of medical experts recommended that the regulatory agency approve the implantable device for use—and the agency often follows such advice.
If approved, the treatment would debut amid a national epidemic of addictions and overdoses involving opioids, which includes prescription painkillers and heroin. The committee concluded that the implantable device could offer a safer way to deliver medication-based treatments for addicts, who desperately need better options. However, dissenting members of the committee expressed concern over the device’s safety and hinted that the need to address the addiction epidemic may have clouded the committee’s judgment.
"We all desperately want something to be available," the committee's acting chairwoman Judith Kramer told USA Today after the committee’s Tuesday vote. But, she said, “I’m very concerned about the precedent this sets." Kramer, a professor emerita at Duke University, was one of the five dissenting committee members.